Trump's tariff policy: Abbott India, Ajanta Pharma to Alembic — pharma stocks crash up to 4%

Pharma stocks dipped on July 24 after President Trump announced a phased tariff plan for imported generic medicines, raising concerns for Indian exporters. Abbott India led losses at 3.69%, prompting fears over the future of American production and long-term impacts on stocks.